NEW YORK, Jan. 24 - Qiagen said on Thursday that it expects total revenue in 2002 to grow 30 percent to $345 million as it prepares a host of new products to launch and begins to streamline its operations in four countries.
Registering provides access to this and other free content.
Already have an account?Login Now.
Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.
Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.
The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.
In Science this week: genetically modified flu virus could be key to new live vaccines, and more.